The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes

There is a paucity of data regarding the impact of mutations on outcomes in accelerated-phase (AP) and blast-phase (BP) myeloproliferative neoplasms (MPNs). Moreover, it is unknown whether mutational status affects survival, as seen in chronic-phase MPNs. Therefore, we performed a retrospective anal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: McNamara, Caroline J., Panzarella, Tony, Kennedy, James A., Arruda, Andrea, Claudio, Jaime O., Daher-Reyes, Georgina, Ho, Jenny, Siddiq, Nancy, Devlin, Rebecca, Tsui, Hubert, Su, Jie, Stockley, Tracy, Sukhai, Mahadeo, Kanwar, Nisha, Chan, Steven, Maze, Dawn, Schimmer, Aaron, Schuh, Andre, Sibai, Hassan, Viswabandya, Auro, Yee, Karen, Minden, Mark D., Kamel-Reid, Suzanne, Gupta, Vikas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199664/
https://ncbi.nlm.nih.gov/pubmed/30327374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018021469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados